J&J’s One-Shot COVID-19 Vaccine Advances to Phase 3 Testing
Johnson & Johnson has advanced its one-shot COVID-19 vaccine into phase 3 testing. The National Institute of Allergy and Infectious Diseases describes this as the fourth candidate to reach this stage. Medscape Medical News …read more